Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Major Depressive Disorder · Migraine · AXSM

Axsome Therapeutics

Axsome Therapeutics patent portfolio — 156 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
One World Trade Center, New York, NY 10007, US HQ
2012 Founded
981 Employees
Public company Type
AXSM · NYSE Ticker
Company details
Status
Public
HQ
One World Trade Center, New York, NY 10007, US
Founded
2012
Employees
981
Programs
1
Drugs
8
Patents
156
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Axsome Therapeutics patents

156 pharmaceutical patents indexed for Axsome Therapeutics. 0 expire within 24 months.

Axsome Therapeutics has 156 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

156 patents

Patent portfolio

Page 1 of 4

  1. US 12390419

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12384743

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12370196

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12357697

    Pharmaceutical compositions comprising bupropion and cysteine

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12357640

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12263145

    Methods of administering solriamfetol to lactating women

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12246023

    Use of reboxetine to treat narcolepsy

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12156914

    Pharmaceutical compositions comprising bupropion and cysteine

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12128052

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12115165

    Use of reboxetine to treat narcolepsy

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12102606

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12102609

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12090126

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12064411

    Methods of administering solriamfetol to lactating women

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12036194

    Methods of administering solriamfetol to lactating women

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12005036

    Methods of administering solriamfetol to lactating women

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12005118

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11998639

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11998552

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11969404

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11957686

    Compositions for delivery of reboxetine

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11944683

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11883408

    Reboxetine to treat narcolepsy

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11872203

    Methods of administering solriamfetol to lactating women

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11872204

    Methods of administering solriamfetol to lactating women

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11865098

    Methods and compositions for treating excessive sleepiness

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11865117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11857528

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11850228

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11850227

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11850226

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11839599

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11839598

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11826354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11826370

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11806354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11801250

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11793776

    Methods of administering solriamfetol to lactating women

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11786488

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11779554

    Methods of administering solriamfetol to lactating women

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11771667

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11771666

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11759522

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11738085

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

156 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.